Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis.

[1]  John H. Zhang,et al.  Vasospasm and p53-Induced Apoptosis in an Experimental Model of Subarachnoid Hemorrhage , 2006, Stroke.

[2]  N. Suttorp,et al.  Streptococcus pneumoniae R6x induced p38 MAPK JNK-mediated Caspase-dependent apoptosis in human endothelial cells , 2005, Thrombosis and Haemostasis.

[3]  John H. Zhang,et al.  Role of c-Jun N-Terminal Kinase in Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage , 2005, Stroke.

[4]  John H. Zhang,et al.  Role of p53 and Apoptosis in Cerebral Vasospasm after Experimental Subarachnoid Hemorrhage , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  John H. Zhang,et al.  Gene Transfer of Extracellular Superoxide Dismutase Failed to Prevent Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage , 2004, Stroke.

[6]  John H. Zhang,et al.  Ras Protein Contributes to Cerebral Vasospasm in a Canine Double-Hemorrhage Model , 2004, Stroke.

[7]  John H. Zhang,et al.  Caspase Inhibitors Prevent Endothelial Apoptosis and Cerebral Vasospasm in Dog Model of Experimental Subarachnoid Hemorrhage , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  A. Manning,et al.  Targeting JNK for therapeutic benefit: from junk to gold? , 2003, Nature Reviews Drug Discovery.

[9]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.